AWM Investment Company, Inc. 13D and 13G filings for NeuroOne Medical Technologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:41 pm Sale | 2024-09-30 | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | AWM Investment Company, Inc. | 397,917 7.700% | -10,416 (-2.55%) | Filing |
| 2024-02-14 3:42 pm Purchase | 2023-12-31 | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | AWM Investment Company, Inc. | 408,333 9.800% | 150,000 (+58.06%) | Filing |
| 2023-02-14 2:40 pm Sale | 2022-12-31 | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | AWM Investment Company, Inc. | 258,333 9.000% | -11,193 (-4.15%) | Filing |
| 2022-02-11 4:54 pm Unchanged | 2021-12-31 | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | AWM Investment Company, Inc. | 269,526 9.990% | 0 (Unchanged) | Filing |
| 2022-02-11 4:20 pm Purchase | 2021-12-31 | 13G | NEUROONE MED TECHNOLOGIES CORP NMTC | AWM Investment Company, Inc. | 269,526 9.990% | 156,525 (+138.52%) | Filing |